Rahul Purwar

This study identifies IL-17A's role in enhancing T-cell viability through mitochondrial complex I in CTCL, suggesting therapeutic targeting of this pathway.

The paper shows that transcriptional fluctuations control cell cycle duration variability in mammalian cells and identifies ways to reduce this variability through network perturbations.